Ledger.Open graph →
SEC Form D · filed February 17, 2026

CollPlant Biotechnologies Ltd

Offering
$4.0M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
REHOVOT, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Yehiel Tal · Ness-Ziona, L3Exec · DirectorJasmine Seror · Rehovot, L3ExecEran Rotem · Ness-Ziona, L3ExecBowman Bagley · Rehovot, L3ExecAlisa Lask · BRIDGEWATER, NJDirectorAbraham Havron · Ness-Ziona, L3DirectorElan Penn · Or Yehuda, L3DirectorOren Fahimipoor · Rehovot, L3ExecBar Abelis · Rehovot, L3ExecJoseph Zarzewsky · Hod Hasharon, L3DirectorPhilippe Bensimon · Ness-Ziona, L3ExecHugh Evans · Baltimore, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗